A summary of the molecular testing recommended in acute myeloid leukemia
<p>Advances in Next-Generation Sequencing technologies (NGS) are revealing germline and somatic mutations that, together with karyotype, determine the diagnosis and subtype of Acute Myeloid Leukemia (AML). Molecular testing is also essential for the genetic risk stratification of patients with...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Annals of Molecular and Genetic Medicine - Peertechz Publications,
2020-04-18.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|